Effectiveness of a simple medication adjustment protocol for optimizing peri-cardioversion rate control: A derivation and validation cohort study.

Heart Rhythm O2
Nelson LuMatthew Bennett

Abstract

Rate control medications are foundational in the management of persistent atrial fibrillation (AF). There are no guidelines for adjusting these medications prior to elective direct-current cardioversion (DCCV). To derive and validate a preprocedural medication adjustment protocol that maintains peri-DCCV rate control and minimizes risk of postconversion bradycardia, pauses, need for pacing, and cardiopulmonary resuscitation (CPR). Consecutive patients with persistent AF awaiting elective DCCV across 2 hospitals were screened for inclusion into derivation, validation, and control cohorts. In the derivation cohort, each patient taking an atrioventricular (AV) nodal blocker had medications adjusted based on heart rate (HR) 2 days before DCCV, and the magnitude of dose adjustment was compared with peri-DCCV HR. The adjustment protocol that achieved the highest percentage of optimal peri-DCCV rate control was tested prospectively in the validation cohort and compared to a standard-of-care control group. The optimal protocol from the derivation cohort (n = 71), based on the 2-day pre-DCCV HR, was to (1) CONTINUE AV nodal blocker for HR ≥ 100 beats per minute (bpm), (2) reduce dose by ONE increment when 80-99 bpm, (3) reduce dose by T...Continue Reading

References

Feb 19, 2011·The Canadian Journal of Cardiology·Jeff S HealeyUNKNOWN CCS Atrial Fibrillation Guidelines Committee
Feb 19, 2011·The Canadian Journal of Cardiology·Anne M GillisUNKNOWN CCS Atrial Fibrillation Guidelines Committee
May 21, 2013·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Toni GrönbergK E Juhani Airaksinen
May 30, 2013·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Dritan PoçiLennart Bergfeldt
Apr 2, 2014·The Canadian Journal of Cardiology·Luc Poirier, Sheldon W Tobe
Mar 19, 2015·The American Journal of Cardiology·Benjamin Adam SteinbergBimal Ramesh Shah
Oct 16, 2015·European Journal of Preventive Cardiology·Jaspal S TaggarMatthew Jones
May 12, 2016·Circulation·Roy M John, Saurabh Kumar
Aug 26, 2016·Lancet·Isabelle C Van GelderBrian Olshansky
Jul 30, 2017·The Canadian Journal of Cardiology·Jason G AndradeJohn Cairns
Apr 12, 2019·Annals of Cardiac Anaesthesia·Bruna Galvão de WafaeHenrique Horta Veloso

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.